Skip to content
  • Massachusetts’ big bet on biotech pays off

    Bloomberg Businessweek - 10/15/2015

    “We knew that we shouldn’t presume to substitute government for the private sector,” says Deval Patrick, who as governor of Massachusetts signed the subsidies into law. (He’s now a managing director at Bain Capital.) “If you can attract enough of the small companies that are on the cutting edge of research, the big companies will follow because they want a front-row seat,” says Barry Bluestone, a Northeastern University economist the state hired to measure the program’s impact.

    Seventy percent of the money disbursed so far has been in the form of direct capital investments that were used to put up buildings and buy equipment. Every dollar Massachusetts spent under the program boosted tax revenue by $1.66, according to Bluestone.

  • Cookies on Northeastern sites

    This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.